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294 HARTL, MARTIN & NEUPERT
PERSPECTIVES AND OVERVIEW
The fundamental discovery that the amino acid sequence of a protein
contains the full information specifying its native, three-dimensional con-
formation marked the beginning of an era of active biophysical research
on the pathways and thermodynamics of protein folding (3). Many purified
proteins when denatured to random coil-like structures can refold spon-
taneously in vitro. This action is driven by small differences in the Gibbs
free energy between the unfolded and native states (33, 38, 92, 97). Conse-
quently, researchers assumed that in vivo folding (acquisition of tertiary
structure) and assembly (acquisition of quarternary structure) of newly
synthesized polypeptides also occur by an essentially spontaneous process
without the help of additional components.
Over recent years, however, several proteinaceous components have
been discovered that directly influence the processes by which newly made
proteins attain their final conformation within the cell. With the exception
of the enzymes protein disulfide isomerase and peptidyl prolyl isomerase,
which catalyze specific reactions that can be rate limiting for folding
(reviewed in 53, 62, 63, 64), these components have been classified 
molecular chaperones (46, 48, 49) or polypeptide-chain binding proteins
(168). They occur ubiquitously in prokaryotes and eukaryotes in the cyto-
sol as well as within organelles (Table 1). Among the best characterized
members of this heterogenous group of components are the constitutively
expressed proteins of the Hsp70 and Hsp60 families (76). In the present
context, their classification as stress- or heat-shock proteins may be some-
what misleading because these components are present in considerable
amounts and fulfill essential functions under nonstressful conditions. Their
expression can be induced under a great variety of cellular stresses, includ-
ing heat shock, that may all have the accumulation ofmisfolded or partially
denatured proteins in common. The term molecular chaperone initially
referred to components such as nucleoplasmin (39, 106) and the chloroplast
chaperonin Rubisco subunit binding protein (47), which assist in oli-
gomeric assembly reactions presumably by preventing the formation of
improper protein aggregates. The definition of molecular chaperone now
includes the recently reported ATP-dependent functions of the various
Hsp60s in actively guiding monomeric polypeptides to their native con-
formations.
This article summarizes the main lines of evidence that form the present
view of Hsp70 and Hsp60 function in the folding and membrane trans-
location of newly synthesized proteins (4, 5, 8, 9, 20, 22, 27, 37, 60, 61, 68,
71, 72, 74, 94, 95, 123, 136, 143, 144, 166, 170, 177, 193, 206). The basic
principle of action common to Hsp70 and Hsp60 appears to be that they
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296 HARTL, MARTIN & NEUPERT
bind to segments of completely or partially unfolded polypeptides that are
released upon ATP hydrolysis in an all-at-once or step-wise fashion. These
chaperones can thus be involved in many cellular processes, preventing
(premature) folding and aggregation, mediating correct folding, or sta-
bilizing certain protein conformations. They may even rescue misfolded
proteins by disassembling aggregates, or regulate the disposal of these
proteins for degradation. Moreover, the general ability of binding and
release shared by Hsp60 and Hsp70 can be utilized in various specialized
processes such as clathrin uncoating and DNA replication. We discuss a
model for the folding of nascent or newly translocated polypeptide chains
based on their sequential and hierarchical interaction with Hsp70 and
Hsp60. The function of the Hsp90 family of stress proteins in maintaining
target proteins in inactive or unassembled states has been reviewed else-
where (29, 198).
CELLULAR CONDITIONS FOR PROTEIN FOLDING
The main functional properties to be expected of factors assisting in physio-
logical protein folding can be derived from a comparison between the
conditions for folding in vitro and in vivo. Folding experiments in vitro
are carried out with completely synthesized, artificially unfolded poly-
peptides (33, 53, 92, 97). Therefore, the same conditions apply equally 
all parts of the folding polypeptide chain. The present concept of the
sequence of events during refolding in vitro of an independently folding
domain (usually about 100 amino acids) of a globular protein can 
summarized as follows: As a result of the entropy-driven collapse of
hydrophobic residues into the interior of the molecule, the multitude of
random coil-like conformations present at high concentrations of denatur-
ant converges within milliseconds towards the so-called prefolded state (23,
33, 38). Secondary structure elements may form even prior to hydrophobic
collapse but become stabilized only within the compact, prefolded con-
formation, thereby providing the framework for further folding (33, 97).
Hence, this early folding intermediate already contains considerable non-
random structure. It is believed to be similar to the molten globule or
compact intermediate states described for certain proteins at intermediate
concentrations of denaturant or at acid pH (23, 102, 157). These inter-
mediates are in rapid equilibrium with the fully unfolded state. Within the
compact intermediate (33), secondary-structure elements are then thought
to become arranged in a slower process (extending over seconds to minutes)
via a limited number of pathways, resulting in the formation of ordered
tertiary structure. This process is accompanied by a further compaction
of the polypeptide as it approaches the transition state of folding described
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PROTEIN FOLDING AND CHAPERONES 297
as a distorted version of the native state. Importantly, progression from the
prefolded state to the native structure depends on long-range interactions
between secondary structure elements that appear to require the presence
of at least a complete protein domain. For example, the deletion of even
a few amino acid residues from either terminus of a polypeptide chain can
prevent folding in vitro that kinetically favors misfolding and aggregation
(58, 169, 182, 200, 201). Independently folding domains are usually sep-
arated along the linear polypeptide chain frequently represented at the
DNA level by distinct exons. However, this is not always the case; for
example, the flavin adenine dinucleotide (FAD)-domain of glutathione
reductase is composed of two noncontiguous parts of the chain that are
134 residues apart (173).
The fact that spontaneous folding of a protein is usually much faster
than its synthesis in the cell (seconds as compared to minutes) implies that
the folding of nascent chains is restricted, a characteristic of the situation
in vivo (168). For example, when the synthesis ofa polypeptide consisting
of 100 amino acids is complete, 40 residues remain within the ribosome.
Such a nascent chain will not be able to fold productively because only
part of a folding domain is available. Instead, it may readily undergo intra-
and intermolecular aggregation. The prefolded state of a protein is thought
to be particularly sensitive to aggregation because of the exposure of
hydrophobic residues (33). One should bear in mind that the concentration
of nascent polypeptide chains in the cytosol of a bacterial cell such as
Escherichia coli can reach 50/~M, the concentration of ribosomes (35).
The local concentration of nascent chains in a polyribosome complex
might be even higher. Aggregation usually poses problems in refolding
experiments at much lower concentrations of folding chains (130). As 
result, folding in vitro often proves very inefficient, while folding in the
cell is generally believed to occur with efficiencies close to 100% (130).
Moreover, within the cell, proteins must fold in a highly viscous 20-30%
protein solution (cytosol or intraorganellar space). Whether spontaneous
folding in vitro is possible under such conditions is unclear.
Thus, polypeptide chains supposedly need to be protected against mis-
folding and aggregation during synthesis. The folding of a single-domain
protein would not occur sequentially as the amino acid residues emerge
from the ribosome but only when the complete protein is available, allow-
ing the productive engagement of its structural elements in long-range
interactions. Clearly, folding as the acquisition of the native tertiary struc-
ture must be a posttranslational process. In larger proteins, of course, an
amino-terminal domain may already have engaged in folding while a more
carboxy-terminal one is still being synthesized (6, 11,62, 201). For example,
influenza hemeagglutinin (containing multiple folding domains) was
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298 HARTL, MARTIN & NEUPERT
observed to acquire some disulfide bonds cotranslationally, but its final
disulfide composition and antigenic epitopes are formed post-
translationally (11). With certain proteins, completion of the process 
folding and assembly can take many minutes after synthesis (26, 85).
Polypeptide chains also encounter the problem of restricted folding
during translocation across membranes. Proteins traverse membranes in
an unfolded conformation and can only fold once translocation is
complete. The following sections discuss the current concepts of how
molecular chaperones mediate the formation of the native conformation
by first preventing folding during synthesis or membrane translocation
and then by mediating the step-wise, ATP-dependent release of poly-
peptide chains that results in folding. The proposed role of these com-
ponents does not violate the principles of folding derived from biophysical
studies with purified proteins. Rather, molecular chaperones may provide
the means to translate these principles into action under physiological
conditions.
THE MEMBERS OF THE HSP70 FAMILY
It may seem a paradox that efficient folding in vivo primarily requires
antifolding activity, the prevention of folding during synthesis. Three lines
of evidence suggest that stress proteins of the Hsp70 class interact with
nascent polypeptide chains, maintaining them in loosely folded con-
formations: (a) Newly synthesized chains were found associated with con-
stitutively expressed Hsp70 (Hsc70) in the cytosol of HeLa cells based
on coimmuneprecipitation of the labeled proteins in cell extracts with
antibodies directed against Hsp70 (5). (b) Cytosolic Hsp70 maintains 
cursor proteins destined for translocation across the membranes of endo-
plasmic reticulum (ER) or mitochondria in open, translocation-competent
conformations (22, 37, 206). Overproduction of DnaK facilitates protein
export to the periplasmic space in E. coli (154). (c) Organellar Hsp70 
the trans side of mitochondrial and ER membranes binds to the incoming
polypeptides (94, 145, 170, 193). This interaction is required for efficient
translocation and for correct folding.
The members of the Hsp70 family have been highly conserved through
evolution (Table 1). In addition to Hsp70s strongly inducible by heat shock
and other forms of cellular stress, constitutively expressed Hsp70s (Hsc70s)
have essential functions under nonstressful conditions (28, 30, 114, 132,
150). These proteins include the E. coli DnaK (66), the yeast cytosolic
proteins Ssa l p and Ssa2p (29) and the Hsc70 of mammalian cells, the so-
called clathrin uncoating ATPase (19, 171). In addition, Hsp70s are found
within subcellular organelles such as mitochondria (the Ssclp of yeast)
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PROTEIN FOLDING AND CHAPERONES 299
(31, 32, 110, 131), chloroplasts (2, 122), and the endoplasmic reticulum
(Kar2p in yeast and BiP in mammalian cells) (74, 133, 134, 143, 166).
These organellar Hsp70s contain typical amino-terminal targeting
sequences directing their sorting to the correct membrane compartment.
All Hsp70s appear to have the following structural and functional features
in common: (a) They bind ATP (19, 60, 96, 199, 207) and consist 
highly conserved amino-terminal ATP-binding domain (~450 residues)
followed by a more variable carboxy-terminal substrate-binding domain
(19, 54, 96, 143); (b) they bind to unfolded or partially denatured poly-
peptides (147; J. M. Flanagan, G. C. Flynn, J. Walter, J. E. Rothman 
D. M. Engelman, submitted), and (c) they utilize the energy of 
hydrolysis to release the bound substrates (60, 111, 112, 134).
Unfoldin# Is Required for Membrane Translocation of Proteins
The finding that proteins have to be unfolded for membrane translocation
strongly stimulated cell biologists’ interest in the mechanisms of protein
folding in vivo (45, 80, 128, 160, 203). For example, stabilizing the folded
conformation of an artificial mitochondrial precursor by binding metho-
trexate to the passenger protein dihydrofolate reductase (DHFR) rendered
the fusion protein unable to traverse the mitochondrial membranes (45).
The import of mitochondrial proteins from the cytosol, which is essential
for the biogenesis of mitochondria, occurs at so-called translocation con-
tact sites where outer and inner mitochondrial membranes are in close
proximity (78, 80). Fusion proteins with a sufficiently long mitochondrial
protein part joined to DHFR could be accumulated as membrane-span-
ning translocation intermediates in contact sites (162). These precursors
reach into the mitochondrial matrix with their amino-terminal targeting
sequence, which is proteolytically cleaved, but leave the folded DHFR
outside the organelle (162, 190). Less than 50 amino acid residues were
sufficient to span the 18- to 20-nm distance from outer surface of outer
membrane to inner surface of inner membrane (163). The membrane-
spanning sequences probably assumed a rather extended conformation.
This is in agreement with the observation that urea denaturation of the
precursor can speed up the translocation process considerably (44, 94,
144).
These results may explain why a loosely folded conformation of pre-
cursor proteins is a general requirement for membrane translocation. But
how is this state of translocation competence achieved? Because trans-
location, at least with mitochondria, is predominantly posttranslational
(204), noncytosolic proteins could (a) either fold following synthesis 
become actively unfolded prior to or during translocation, or (b) be main-
tained in unfolded conformations as long as they are awaiting translocation
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300 HARTL, MARTIN &NEUPERT
in the cytosol. This latter mechanism applies to mitochondrial protein
import and to posttranslational transport of proteins into the ER.
Cytosolic Hsp70 Stabilizes Precursor Proteins for
Translocation
The presence of amino-terminal presequences retards the folding of puri-
fied precursor proteins as compared to their mature-sized counterparts
(107, 160, 161). Precursor proteins may thus efficiently interact with chap-
erones for prolonged periods. In the bacterial cytosol, several components
including SecB (25, 77, 116, 196), GroEL (8, 101,108, 154), and the Hsp70
DnaK (154) stabilize precursor proteins, while in eukaryotes cytosolic
Hsp70s (ct-Hsp70s) appear to be most important in this respect (36).
SecB, probably a pentamer of 15-kilodalton (kDa) subunits, binds to the
presequenee and the mature part of secretory precursors (25, 77, 107,
116, 196). Because SecB, in contrast to Hsp70 and GroEL, lacks ATP-
hydrolyzing activity, release from SecB appears to be accomplished by
transfer of the bound protein to SecA, a peripheral ATPase of the trans-
location apparatus in the E. eoli membrane (77).
Although binding ofct-Hsp70 probably also prevents folding in the ease
of nascent chains destined to remain in the eukaryotic cytosol (5), newly
synthesized precursor proteins destined for membrane translocation pro-
vide more direct genetic and biochemical evidence for such a function (22,
36, 37, 136, 194, 206) (Figure 1, below).
The yeast Saccharomyces cerevisiae contains two genes coding for ct-
Hsc70s (Ssalp and Ssa2p) and two coding for inducible ct-Hsp70s (Ssa3p
and Ssa4p) (28, 29). A yeast mutant in which SSA1, SSA2, and SSA4
were disrupted was nonviable but could be rescued if transformed with a
centromeric plasmid carrying the SSA1 gene under the control of the
GALl promoter (37). When the ceils were shifted from galactose-con-
taining medium to glucose, the levels of ct-Hsc70s decreased, accompanied
by the accumulation of precursor proteins destined to mitochondria and
endoplasmic reticulum outside the organelles. The requirement of Hsp70
for protein translocation was also demonstrated in vitro using isolated
microsomes and precursor proteins synthesized in a wheat germ lysate
lacking functional Hsp70 (22). At least one further cytosolic activity was
required, possibly for the release of the precursors from Hsp70 (136,
206). This activity could be inhibited by the sulfhydryl reagent N-ethyl
maleimide (NEM) (136). The eukaryotic cytosol may contain homologues
of the bacterial heat-shock proteins DnaJ and GrpE, which in E. eoli are
known to cooperate with DnaK in phage 2 DNA replication (43, 66) 
regulating the ATPase activity of DnaK (113). Whether DnaJ- and GrpE-
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PROTEIN FOLDING AND CHAPERONES 301
like components are generally required by Hsp70s to execute their various
functions remains to be seen.
Organellar Hsp70 in Protein Translocation and Foldiny
MITOCI-IOND~tIA The translocation of a folded protein domain, which has
to lose at least all of its tertiary structure during membrane transport,
can occur without a direct requirement for ATP or the membrane potential
across the inner membrane (152). What then provides the energy for the
vectorial movement of the polypeptide chain across the membranes? At
low levels of ATP, the imported proteins are bound to the heat-shock
proteins in the mitochondrial matrix, mt-Hsp70, and Hsp60 (94, 144)
(Figure 1). Apparently, interaction with the mitochondrial Hsp70, Ssclp,
is directly required for translocation (94, 145, 170). In a temperature-
sensitive yeast mutant affecting the gene coding for Ssclp, the transfer
of precursor proteins into mitochondria was defective (94). Precursor
polypeptides were arrested during translocation spanning outer and inner
membranes at contact sites. This block could be overcome in vitro when
the precursor was first unfolded using 8 M urea and then rapidly diluted
into a reaction containing the isolated mutant organelles. However, the
precursor imported under these conditions remained in a highly protease-
sensitive, incompletely folded conformation. Therefore, the mitochondrial
Hsp70 apparently has a dual role in translocation and folding of imported
proteins. Folding requires the transfer of the newly translocated poly-
peptides from mt-Hsp70 to Hsp60 (see below), a step that is blocked 
the Ssclp mutant.
The energy resulting from binding of the extended amino terminus of
the precursor protein to mt-Hsp70 could be utilized to successively unfold
parts of the precursor still outside the organelle (141). Multiple molecules
of mt-Hsp70 could bind to the traversing chain, thereby pulling it through
the membrane. A typical precursor protein would be bound to cytosolic
Hsp70 (22, 37). Both release from ct-Hsp70 (153, 206) and transfer of 
imported polypeptide from mt-Hsp70 to Hsp60 require ATP hydrolysis (F.
U. Hartl & T. Langer, unpublished data). In this model for the molecular
mechanism of membrane translocation, multiple molecules of mt-Hsp70
would bind with high affinity to the extended precursor polypeptide whose
folding is restricted by the membrane. Fewer molecules of ct-Hsp70 would
be associated with the precursor in the cytosol that has assumed the
conformation of a collapsed prefolded state during or after synthesis.
ENDOPLASMIC RETICULUM The lumen of the ER contains an Hsp70 that
was initially identified by its association with immunoglobulin heavy
chains. This immunoglobulin heavy chain binding protein (BiP) (9, 74),
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302 HARTL, MARTIN & NEUPERT
also known as glucose-regulated protein Grp78 (134), is identical to yeast
Kar2p (143, 166), which is inducible by various stress conditions including
glucose restriction and the accumulation of secretory precursors. A tem-
perature-sensitive KAR2 mutant shows a defect in translocation remi-
niscent of that seen in the mutation affecting the mitochondrial Hsp70
(193). At the nonpermissive temperature, precursors destined for the 
accumulated in the cytosol. Interestingly, Kar2p genetically and physically
interacts with the Sec63 protein (167), a membrane component protruding
into the ER lumen with a domain homologous to DnaJ. The defect in the
KAR2 mutant could be reproduced using isolated microsomes of mutant
cells and precursor proteins synthesized in vitro (R. Schekman & M. Rose,
personal communication). Surprisingly, translocation into reconstituted
microsomes was observed even in the apparent absence of BiP (142).
However, very small amounts of BiP that might have escaped detection
could have been sufficient to accomplish the translocation of the small
quantities of radiolabeled precursor protein.
Requirement of Hsp7O for Protein Assembly in the ER
In addition to its role in protein translocation, BiP has an important
function in oligomeric assembly of proteins in the ER (89). In reviewing
the results of the numerous studies analyzing the interaction of BiP with
secretory proteins, our discussion focuses on those observations that are
more directly related to protein folding. In fact, BiP was the first Hsp70
recognized as a polypeptide-chain binding protein because of its associ-
ation with immunoglobulin heavy chains in pre-B cells (74). The heavy
chains remain permanently bound to BiP in these cells and await the
synthesis of light chains necessary for assembly of complete immuno-
globulins (9, 85). Under various conditions leading to the accumulation
of incompletely folded, modified, or nonassembled proteins in the ER,
these proteins are detected as complexes with BiP (42, 68, 90, 95). For
example, mutated forms of the influenza virus hemeagglutinin, which
cannot fold and assemble correctly, form stable complexes with BiP. In
contrast, several normal proteins on the native folding pathway appear to
interact only transiently (68, 89, 95, 100). The treatment of CHO cells with
tunicamycin or exposure to glucose starvation causes the accumulation of
undergylcosylated, misfolded proteins associated with BiP (42, 109). Under
these conditions, BiP is itself induced--hence the term glucose regulated
protein Grp78 (109, 134). The primary stimulus for induction seems to 
the presence of malfolded proteins rather than abnormal glycosylation
(100). In addition to BiP, another stress protein of the ER, Grp94, 
induced when incompletely folded or assembled proteins accumulate (100,
109).
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Bound proteins are released from BiP in a process requiring ATP
hydrolysis (134). Metabolically poisoning cells to decrease the level of ATP
prevented the trimerization of a mutant VSV G protein in the ER (~11).
Restoration of normal ATP levels allowed trimerization to proceed. These
results indicated the existence of a pool of ATP in the lumen of the ER
that had previously been unknown. The ATPase activity of purified BiP
was found to be reduced in the presence of Ca2 + (96), raising the possibility
that by modulating the level of Ca2÷ in the ER, the capacity of BiP to
retain newly made proteins could be regulated. Indeed, Ca2÷ reportedly
counteracted Mg-ATP-dependent release from BiP and secretion of vari-
ants of the T-cell antigen receptor ~ chain (179).
Secretory proteins must fold and assemble before leaving the ER
through the secretory pathway. The main function of BiP could therefore
be to retain normal proteins until assembly with other subunits is complete
(84) or to prevent abnormal proteins from leaving the ER by channeling
them into the ER degradation system (90, 98). However, BiP (up to 
of lumenal ER protein) is a soluble component. It leaves the ER with the
bulk flow and is retained via its carboxy-terminal KDEL signal (HDEL
in the case of S. cerevisiae Kar2p) by a recycling mechanism between 
salvage compartment and the ER (135, 151). Whether BiP-bound proteins
are retained by the same mechanism is unknown. BiP may well play a
general role in folding and assembly of proteins newly translocated into
the ER. Data indicating that BiP is required for the physiological folding
of a monomeric protein are not yet available, however.
Molecular Mechanism of H~p70 Action
SUBSTRATE RECOGNITION Hsp70s do not interact with defined sequence
motifs. Their broad pattern of polypeptide recognition allows them to
participate in many cellular processes. The affinity for certain substrates,
however, may vary among the different members of the Hsp70 family. For
example, clathrin cages stimulate the ATPase activity of cytosolic Hsc70
but not that of BiP (60). The principle of Hsp70 function is illustrated
by the demonstration that various Hsp70s preferentially recognize short
synthetic peptide sequences that may be exposed by unfolded or partially
folded polypeptides. A first study using a few selected 10- to 15-residue
peptides did not reveal any preference for a specific sequence or for a
certain distribution of charge or hydrophobicity (60). Most peptides
analyzed bound to Hsp70, but the binding affinities varied over three
orders of magnitude. Recently, an extensive systematic study demonstrated
that peptides of seven or eight residues optimally stimulated the ATPase
of BiP (61). Consequently, the binding selectivity of BiP was tested using
a mixture of randomly synthesized heptameric peptides. Sequencing the
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collective of bound peptides showed an enrichment of aliphatic amino acid
residues (Val, Leu, Ile) and methionine at all positions of the bound peptide
chains that was most pronounced within the region of the peptide core.
Previously, Pelham (148, 149) proposed an interaction of Hsp70 with
hydrophobic residues exposed by unfolded or partially denatured poly-
peptides. While most amino acids could be tolerated, charged residues and
prolines, which are preferentially surface-exposed in native proteins, were
excluded from the binding site (61). Random 7-mer peptides containing
an average of 1.6 aliphatic residues bound efficiently to BiP. Coating by
Hsp70 of the respective segments of nascent chains (statistically occurring
every 16 residues in a globular protein) (61) might thus prevent (mis)folding
and aggregation during synthesis and maintain the sequences emerging
from the ribosome in an extended conformation (Figure 1). However,
Hsp70s could probably hold a complete polypeptide chain of up to several
hundred amino acid residues in a random coil-like state within a physio-
logical environment. The protein might rather be stabilized in a collapsed
prefolded conformation when some of the attached Hsp70 molecules (per-
haps those bound with lower affinity) fall off either spontaneously or upon
ATP-dependent release; other Hsp70 molecules would remain bound more
firmly (Figure 1). After completion of synthesis, the protein would thus 
stabilized in an open, perhaps molten globule-like conformation, the likely
equivalent of the so-called translocation-competent state (15).
In the case of proteins that have already undergone folding to the native
state but expose hydrophobic peptide segments because of denaturation,
the free energy of Hsp70 binding could be utilized to resolve misfolding
or aggregation. Such a function may be reflected by observations made
with DnaK in a model reaction containing aggregates of thermally
denatured RNA polymerase (177). Dependent on ATP-hydrolysis, DnaK
present in at least stoichiometric amounts to RNA polymerase can dissolve
the aggregates, resulting in reactivation of the enzyme. Certain native
proteins might make use of surface-accessible, extended sequences to
attract the attention of Hsp70. DnaK cooperates with the heat-shock
proteins DnaJ and GrpE in specific disassembly reactions; for example,
this occurs in bacteriophage 2 DNA replication by dissociating the DnaB
protein from the 2P protein, which then allows the helicase to function
(40, 43, 66). Similarly, DnaK and DnaJ activate the RepA initiator protein
that recognizes the origin of P1 replication by converting RepA dimers
into monomers (202).
The three-dimensional structure of the carboxy-terminal domain of
Hsp70, most likely responsible for specific substrate binding (19), has not
yet been determined. However, molecular modeling based on a comparison
of the carboxy-terminal domains of numerous Hsp70s from different
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sources suggested an interesting similarity with the ~-1 and ~-2 domains
of the human major histocompatability antigen (MHC) class I protein (56,
165). One model proposes a peptide binding cleft for Hsp70 that, in
contrast to that of the MHC class I molecule, would be lined pre-
dominantly by polar and charged amino acid residues (57). Another
hypothesis predicts a peptide binding cleft containing both polar and
apolar residues (165). This prediction seems plausible given that Hsp70
can accommodate both polar and apolar residues, possibly via interaction
with the polypeptide backbone.
ATP HYDROLYSIS REQUIRED FOR RELEASE Although the binding of unfolded
proteins or peptides to Hsp70 likely is independent of ATP, their release
requires ATP hydrolysis by Hsp70 (24, 60, 61, 84, 111, 134, 207) and
probably cooperation with additional factors such as DnaJ and GrpE
or perhaps their homologues (66, 136, 206). These heat-shock proteins
stimulate the ATPase activity of DnaK (113). ATP hydrolysis, at least 
the case of BiP, may be regulated by Ca2+ (96, 179). The binding 
nucleotides can modulate the conformation of Hsp70 as revealed by
changes in its sensitivity towards proteases (96). While ATP stabilizes
Hsc70 in monomeric form, the presence of ADP favors the formation of
dimers (172). The affinity of Hsp70 for ADP was found to be approxi-
mately sixfold higher than that for ATP. The ADP-bound form of Hsp70
also appears to associate with unfolded polypeptides more avidly. The
release of the bound substrate could thus involve the exchange of ADP by
ATP and its concurrent or subsequent hydrolysis (147). It is assumed that
a conformational change of the amino-terminal ATP-binding domain
of Hsp70 may be transferred to the carboxy-terminal substrate-binding
domain, resulting in a decrease of binding affinity. Correspondingly, sub-
strate binding stimulates the ATPase activity of Hsp70 (60, 61).
The ATP binding and hydrolytic activity is contained in the approxi-
mately 44-kDa amino-terminal domain of Hsp70 that is preserved upon
limited proteolysis of the intact molecule (19, 96, 143). The recent res-
olution to 2.2/~ of the three-dimensional structure of the ATP binding
domain of Hsc70 (54) revealed that its fold is almost identical to that 
the globular monomer of actin (55). This observation is quite surprising
because Hsc70 and actin share no sequence similarity. The structure of the
nucleotide-binding site of Hsp70 is also similar to that of hexokinase (54).
The ATP requirement for release from Hsp70 is probably reflected in
the dependence of protein translocation across subcellular membranes on
cytosolic ATP (80, 128, 189). The absence of ATP renders precursor
proteins destined for mitochondria (153) and the ER (206) incompetent
for membrane translocation. On the other hand, studies of the import of
Annual Reviews
www.annualreviews.org/aronline
A
nn
u.
 R
ev
. B
io
ph
ys
. B
io
m
ol
. S
tru
ct
. 1
99
2.
21
:2
93
-3
22
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 M
et
eo
ro
lo
gi
sc
he
s I
ns
tit
ut
 - 
U
ni
ve
rs
ity
 M
ue
nc
he
n 
on
 1
1/
19
/0
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
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artificial precursor proteins into mitochondria that do not (or only weakly)
interact with Hsp70 showed that translocation was independent of ATP
(Figure 1) (152).
THE MEMBERS OF THE HSP60 FAMILY
Evidence indicates an active role in mediating protein folding for the
members of the Hsp60 family of stress proteins (12, 20, 71, 72, 123, 127,
144). The Hsp60 components have been defined as a subclass of molecular
chaperones termed chaperonins (83) (Table 1). They are found in 
bacterial cytosol and in the inner compartment of chloroplasts (stroma)
and mitochondria (matrix) (49, 76). Like certain Hsp70s, these proteins
are constitutively expressed. While GroEL can be induced severalfold
under heat-shock conditions, expression of mitochondrial Hsp60 is stimu-
lated by heat stress only two- to threefold (20). The chaperonins also
exhibit a weak ATPase activity (18, 123, 192) but are structurally unrelated
to the Hsp70s (except for a carboxy-terminal methionine-rich sequence
of unknown function) (10). They form large tetradecameric complexes
consisting of two stacked rings of seven 60-kDa subunits each (86, 87, 91,
159).
The chloroplast chaperonin Rubisco subunit-binding protein was
initially found associated with the newly imported small subunits and the
chloroplast-encoded large subunits of ribulose bisphosphate carboxylase
oxygenase (Rubisco) but not with the completely assembled enzyme (4,
16, 47, 137, 138). This association was noncovalent and required ATP
hydrolysis for dissociation. The Rubisco binding protein consists of dis-
tinct but sequence-related c~ and/~ subunits that form mixed 14-mer com-
plexes (82). The 61-kDa c~ subunit is 46% identical to the product of the
9roEL gene of E. coli (83).
The 9roEL gene is part of the 9roE operon that also contains the
information for a smaller protein, GroES (also known as chaperonin 10).
In its functional state, GroES exists as an oligomer (probably a heptamer)
of 10-kDa subunits (18, 66). Various mutations in 9roEL and 9roES affect
the assembly of 2 phage capsids but not cell growth of the host (67, 178,
180, 183). However, gene deletion experiments showed that both genes are
essential for growth at all temperatures (51). The GroE proteins are the
major heat-shock proteins of E. coli. The synthesis of GroEL can increase
from a basal level of about 2% of total cellular protein at 37°C to about
12% at 46°C (140). Ample evidence suggests a physical interaction 
GroEL and GroES as well as their involvement in folding and assembly
of authentic and foreign proteins (66). Overexpression of the 9roE operon
suppressed several heat-sensitive mutations, probably by maintaining the
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~ GroES
B
~ 8 GYFOSOL
/
bHsp70~
_ _ _
" I I r X + OnaJ, G~E ~
Hsp60
Fi#~re ~ Hypothetical mode] £or the d~Ecrcnda] £uncdo~ o£ Hsp?0 and
protein £o]dJn~. (~) Fo]dJ~ Jn the bactc~a] cEtoso[. Hascc~t poiypcpddcs ~tcract with
~ bc£orc rcach~n~ GroWL. Re]case o£ fi~hfly boun~ ~a~ may rc~uJrc the coopcrat~o~
o£ heat-shock p~otcins Dna3 a~d GrpE. ~ s~]c cycle o£ Gro~L/G~oES dependent £o]d~
~s shown. ~ssociat~on with ~ro~S may J~hJbJt o~c o£ the ?-mcr rin~s o£ O~oEL £o~ substratc
bindin8 (35). Whether top and bottom sur£accs o£ Oro~ arc J~JtJa]]y cquJ~a]cnt 
Eo]dJng is assumed to occur by a suffacc-mcdJatcd process. ~-~T~ indicates the
mcm ~or ~TP hydrolysis. See text £or ~et~{]s. (B) ~o]dJnB Jn the mJtochondrJa] mat~x.
synthesized precursor proteins arc stabilized Jn a ]oosc]y £o]dcd con£o~atJon by cytoso]~c
Hsp?0 (c[-Hsp?0). ~uring and a~tcr membrane tr~ns]ocatJon, the po]ypepddes interact with
mhocho~dd~] Hsp?0 (mt-Hsp?0). Re]case from Hsp?0 and t~ans£cr to Hsp60
may ~cquJrc putative homo]o~ucs o£ ~n~3 and ~. See text £or details_ Abbreviations ate:
OM, outer mitochondfia] membrane; ~, Jn~er mhocho~dfial membrane.
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308 HARTL, MARTIN & NEUPERT 
affected proteins in a functional conformation at the nonpermissive tem- 
perature (188). Increasing the levels of GroEL and GroES allowed the 
efficient assembly of heterologously expressed prokaryotic Rubisco (72). 
At wild-type levels of GroE, similar amounts of Rnbisco were synthesized, 
but the newly made subunits could not assemble into the functional com- 
plexes. Overexpression of GroEL and GroES was also required for the 
functional expression of a thermolabile, heterodimeric luciferase at  elev- 
ated temperatures (A. Escber & A. A. Szalay, personal communication). 
GroE overproducers could become useful in the future to facilitate the 
biotechnological production of large amounts of foreign proteins in bac- 
teria that often results in the formation of inclusion bodies (88, 130). 
More recently, an Hsp60 was identified in mitochondria of Tetrahymena 
hermuphila (125, 126) and in the mitochondria of various other species 
including humans (93, 131, 164, 195). The protein is synthesized con- 
stitutively as a cytosolic precursor and is assembled within the organelles. 
Hsp60 is coded for by an essential gene and constitutes roughly 1% of the 
total mitochondrial protein in yeast or Neurospora crassa under non- 
heat-shock conditions (20, 91, 164). A homologue of the GroES protein 
exhibiting significant sequence similarity has been discovered in mito- 
chondria ( I  18) and is probably present in chloroplasts as well (A. Gatenby, 
personal communication). The chaperonins seem to be restricted to archae- 
bacteria, eubacteria, and to organelles of endosymbiotic origin. However, 
a recent report states that acomponent of the eukaryotic cytosol, theTCP- 
1 protein complex, is remotely related to Hsp60 ( I )  (see below). 
Multiple Functions of Mitochondrial Hsp60 
Mitochondria are a particularly suitable system for studying processes of 
physiological protein folding and assembly (76). In order to multiply by 
growth and division, these organelles have to import most of their proteins 
from the cytosol in an unfolded conformation (78, 80). Protein import and 
subsequent folding can be faithfully reproduced with isolated mito- 
chondria and precursor proteins synthesized in vitro. Protein synthesis 
and physiological folding can be separated experimentally because of the 
posttranslational nature of the uptake reaction, a unique advantage of this 
system. 
MONOMERIC CHAIN FOLDING A N D  OLIGOMERIC ASSEMBLY Evidence for a 
function of Hsp60 in protein assembly came from the analysis of the 
temperature-sensitive lethal yeast mutant mf4,  which is defective in the 
MIF4 genecoding for Hsp60 (20,21,121; H .  Koll, B. Guiard, J .  Rassow, 
J. Ostermann, A. L. Horwich, et al, submitted). Because of a single amino 
acid substitution (A. Horwich, unpublished data), the altered Hsp60 under- 
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goes a conformational change at  the nonpermissive temperature that 
results in the loss of function. Proteins such as the precursor of the fi 
subunit of the F,-ATPase or the trimeric matrix enzyme ornithine trans- 
carbamylase are imported normally by the mutant mitochondria and are 
proteolytically processed, but cannot assemble into oligomeric complexes 
(20). The unassembled subunits have a tendency to aggregate in the matrix 
compartment. 
The Hsp60 14-mer is also required for its own assembly (21). When 
wild-type Hsp60 monomers were expressed in mf4 mutant cells, they 
could not form a functional Hsp60 14-mer complex at the nonpermissive 
temperature. Thus, the machinery necessary for the folding and assembly 
of many if not most mitochondrial proteins cannot undergo self-assembly 
in vivo (21). On the other hand, a study of the (re)assembly of urea- 
denatured GroEL in vitro concluded that 14-mers are first formed spon- 
taneously and then catalyze further assembly in a Mg-ATP dependent 
reaction (115). Self-assembly is also possible for GroES, at least under 
appropriate conditions in vitro (124). 
A biochemical analysis of the interaction between imported proteins 
and mitochondrial Hsp60 revealed that the basic role of this chaperonin 
probably lies in mediating the folding of monomeric polypeptide chains 
(144). When the cytosolic protein mouse dihydrofolate reductase (DHFR) 
was imported into mitochondria as a fusion protein carrying a cleavable 
amino-terminal targeting sequence, its folding into the protease-resistant, 
native conformation occurred with a half-time of about 3 min. This was 
much slower than import into mitochondria of the urea-denatured precur- 
sor. On the other hand, DHFR is known to fold rapidly in vitro (123, 
184). This retardation of folding in mitochondria results from complex 
formation with Hsp60 (144). When the mitochondria used in the import 
reaction were depleted of ATP, the complex between DHFR and Hsp60 
was stable and could be isolated from mitochondrial extracts. The Hsp6O- 
bound DHFR was highly sensitive towards digestion by proteinase K, 
indicating that it was in an unfolded or incompletely folded conformation. 
ATP hydrolysis and an additional factor were necessary to allow folding 
of the Hsp60-associated protein. E. coli GroES can be substituted for this 
factor (118; F. U. Hart1 & A. L. Horwich, unpublished data). In the 
absence of the mitochondrial GroES, the ATP-dependent folding reaction 
slowed down, allowing the detection of a partially folded form of DHFR 
that was still associated with Hsp60 (144). Folding of DHFR in mito- 
chondria could also be blocked by pretreatment of the organelles with 
NEM. Under these conditions, the DHFR fusion protein transiently 
associated with Hsp60 but then formed incorrectly folded aggregates. 
These results suggested an active function of Hsp60 in protein folding that 
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is not simply explained by binding and release of the incompletely folded
polypeptide (144) (Figure 1). The Rubis¢o subunit-binding protein prob-
ably has a similar role in the folding of proteins imported into chloroplasts
or synthesized within the organelles (117, 156).
ANTIFOLDING IN PROTEIN EXPORT In addition to the functions in folding
and assembly, Hsp60 is required for the export of certain proteins from
the matrix to the intermembrane space of mitochondria (20, 78; H. Koll,
B. Guiard, J. Rassow, J. Ostermann, A. L. Horwich, et al, submitted).
For example, the cytosolic precursor of cytochrome b2 is first imported
completely and is then transported back across the inner membrane fol-
lowing a bacterial-type export pathway (79). This mechanism of intra-
mitochondrial sorting is thought to reflect the endosymbiotic origin of
mitochondria from prokaryotic ancestors (78). The information for export
of cytochrome b2 is contained in a hydrophobic amino-terminal signal
sequence. Evidence that Hsp60 is involved in protein sorting to the inter-
membrane space again came from analyzing the Hsp60-deficient mutant
mif4 (20). The mutant mitochondria accumulated incompletely processed
forms of cytochrome b2 and of the Rieske Fe/S protein, which follows a
similar route to the intermembrane space (81). These findings suggested 
role for Hsp60 in maintaining precursor proteins imported into the matrix
in an open conformation competent for export across the inner membrane.
A similar function in bacterial protein export has been observed with E.
coli GroEL for a very limited subset of secretory precursors (8, 101, 154),
while the main chaperone for bacterial export appears to be SecB (25, 77,
116, 160, 161,196).
How is the antifolding function of Hsp60 related to its role in mediating
folding? A fusion protein consisting of the presequence of the inter-
membrane-space protein cytochrome b2 and DHFR was imported into
ATP-depleted mitochondria. A stable complex with Hsp60 formed in
which DHFR was unfolded. Strikingly, the DHFR moiety could not fold
when ATP was added. Folding occurred only after translocation to the
intermembrane space had taken place (H. Koll, B. Guiard, J. Rassow, J.
Ostermann, A. L. Horwich, et al, submitted). The hydrophobic export
sequence may retard the folding of the mature protein part as demonstrated
for certain bacterial secretory proteins such as the precursor of maltose
binding protein (160, 161). Rebinding to Hsp60 following ATP-dependent
release could be more rapid than folding, thus preserving an unfolded
conformation of the protein. This possibility would be in agreement with
results obtained by analyzing the interaction between pre-fl-lactamase and
GroEL in vitro (8, 103). A model of kinetic partitioning has been proposed
to interpret the binding properties of secretory precursor proteins to SecB
(75). In contrast to the chaperonins, SecB does not hydrolyze ATP.
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Molecular Mechanism of Chaperonin Action
To understand the molecular details of the mechanism by which the chap-
eronins mediate folding and assembly, one must reproduce their function
in vitro using the purified components. The first important information
came from studies reconstituting the GroEL- and GroES-dependent
homooligomeric assembly of prokaryotic Rubisco (71). Rubisco subunits
completely unfolded in 6 M guanidinium chloride or denatured at acid pH
were found to form stable binary complexes with GroEL, presumably as
partially folded intermediates. This interaction prevented the aggregation
of the protomers otherwise observed upon dilution from denaturant. ATP
hydrolysis and the cooperating component GroES proved to be necessary
for the formation of the assembled, biologically active enzyme (71). 
discussed below, the Rubisco protomers likely underwent partial folding
at GroEL and were ultimately discharged in a conformation competent
for assembly with another subunit. Similar results were reported for the
chaperonin-dependent assembly of dimeric citrate synthase (12), a protein
whose refolding from denaturant had been unsuccessful so far. Recently,
studies on the GroE-mediated refolding of monomerie, dihydrofolate
reductase (123, 191) and rhodanese (123, 127) shed new light on 
mechanism of GroE action. Notably, all the in vitro studies consistentlY
failed to provide evidence for a function of GroEL in refolding protein
aggregates.
STABILIZATION OF AN EARLY FOLDING INTERMEDIATE The GroEL 14-mer
complex appears to bind only one or perhaps two protein molecules, as
demonstrated using various substrate proteins ranging in size between
~ 20-50 kDa (71,103, 108, 123, 191). The stoichiometry of bound poly-
peptides per GroEL oligomer may increase’with smaller substrates. One
approach towards understanding chaperonin-mediated folding relies on
(a)defining the conformation in which a protein substrate is stably bound
by GroEL and (b) characterizing intermediates associated with the chap-
eronin during the folding process. The conformation of GroEL-bound
DHFR from chicken and of bovine rhodanese were examined using fluo-
rescence spectroscopy (123). Binding was performed by adding the sub-
strate proteins from 6 M guanidinium chloride to GroEL containing buffer
in the absence of ATP hydrolysis. The intrinsic tryptophanyl fluorescence
of the bound polypeptides was used to probe their tertiary structure. This
approach was possible because both the sequences of GroEL and GroES
lack tryptophans (83, 87). In both cases, the maximum wavelength 
emission was at an intermediate position between that of the native and
fully unfolded conformations (123). A marked increase in the fluorescence
intensity, probably resulting from dequenching of Trp24, accompanied
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312 HARTL, MARTIN & NEUPERT
unfolding of DHFR. The GroEL-associated DHFR showed a fluorescence
intensity nearly as high as DHFR unfolded in 6 M guanidinium chloride,
indicating that the conformation stabilized by GroEL lacked the specific
tertiary structure present in the native protein. This observation was in
agreement with the very high protease sensitivity of the GroEL-bound
species (123, 191). Fluorescence quenching experiments showed that the
tryptophans in GroEL-bound DHFR and rhodanese were better protected
from solvent than in the fully unfolded conformations but significantly
more accessible than in the native structures (123). These findings suggested
that the GroEL-associated polypeptides were in a partially folded con-
formation perhaps similar to the molten globule (23, 34, 102, 158) 
compact intermediate (33) states. An analysis of the binding of the fluo-
rescent probe anilino-naphthalene sulfonate (ANS), whose fluorescence
depends on the hydrophobicity of its environment, corroborated these
results. Adsorption of ANS is typically observed with loosely folded pro-
tein conformations such as the molten globule (23, 157, 158, 175). Both
GroEL-bound DHFR and rhodanese showed strong ANS fluorescence
that was observed neither with the fully unfolded nor with the native
proteins (123).
The nature of the structural elements recognized by GroEL is still
unknown. Available evidence suggests that these elements are present in
practically every protein whose interaction with GroEL has been tested so
far. They could be extended peptide sequences, certain secondary structure
elements, or conformational arrangements such as hydrophobic clusters
or patches that would be transiently exposed by early folding intermediates
resembling the molten globule. Using transferred nuclear Overhauser effect
(NOE) measurements, Landry & Gierasch (104) recently showed that 
13-amino acid residue peptide representing the amino-terminal e-helix of
rhodanese binds to GroEL in an e-helical conformation, albeit with low
affinity. These investigators proposed that GroEL may recognize the
hydrophobic face of amphiphilic e-helices occurring at the amino terminus
of nascent polypeptide chains (105). Assuming that the reported inter-
action was specific, these findings will be very important for eventually
understanding the functional principle of GroEL in facilitating protein
folding. The binding of secondary structure elements suggests a mechanism
of action distinct from that proposed for the members of the Hsp70 family
of molecular chaperones (see above).
FOLDING AT GroEL A molten globule-like conformation may represent the
likely conformation of a polypeptide competent for translocation across
membranes (15). The molten globule may also be the global conformation
of newly synthesized proteins in which they enter the pathway of chap-
Annual Reviews
www.annualreviews.org/aronline
A
nn
u.
 R
ev
. B
io
ph
ys
. B
io
m
ol
. S
tru
ct
. 1
99
2.
21
:2
93
-3
22
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 M
et
eo
ro
lo
gi
sc
he
s I
ns
tit
ut
 - 
U
ni
ve
rs
ity
 M
ue
nc
he
n 
on
 1
1/
19
/0
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
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eronin-mediated folding. Initiation of folding by Mg-ATP and GroES
resulted in the progression of GroEL-associated rhodanese to a more
compact folding intermediate (123). This process was accompanied by 
decrease in ANS fluorescence and an increase in intrinsic protease resist-
ance. Similar results were obtained with folding of DHFR (123). These
more compact intermediates were still bound to the GroEL double ring,
suggesting that at least a partial folding reaction took place in very close
association with the chaperonin.
The process of folding at the surface of GroEL depends critically on the
presence of GroES. In the absence of GroES, ATP hydrolysis by GroEL
appears to result in the complete release of the bound protein (123, 191).
In DHFR, which folds spontaneously in vitro, this release was sufficient to
allow the formation of the native structure. However, following complete
release, DHFR could rebind to GroEL before completing folding, thus
explaining why GroEL retarded the reactivation of DHFR as compared
to the rate of spontaneous folding (123). In contrast, complete release 
the absence of GroES did not lead to reactivation of rhodanese but rather
to efficient cycling between the GroEL-bound and free states. Unlike
DHFR, rhodanese cannot fold efficiently in vitro. Upon dilution from
denaturant, the protein forms a collapsed intermediate that aggregates
rapidly (181). This aggregation is prevented by binding of the rhodanese
intermediate to GroEL (123, 127). The fact that complete release from
GroEL in the absence of GroES did in fact occur could be proven using
the pseudo-unfolded protein casein (146, 197) as a competitor for binding
to GroEL. In the presence of Mg-ATP, casein displaced GroEL-bound
DHFR or rhodanese (123). The released DHFR then folded spon-
taneously, while the fate of rhodanese was aggregation. Polypeptides fold-
ing at GroEL were protected from displacement by casein when GroES
was present. Apparently during folding, the proteins were isolated from
the bulk phase of the solution. According to these results, GroEL would
have to interact with more than one segment of the protein substrate.
Folding could occur by releasing these segments in a step-wise or sequential
manner, a process that requires regulation by GroES 023). The substrate-
binding region of GroEL has not yet been identified. Binding to GroEL
may occur at the central area of one of the 7-mer rings where all of its
subunits could contribute binding sites for segments of the polypeptide
chain, perhaps forming a kind of channel. Only one of the 7-mer rings
may be active at a time for binding dependent on regulation by GroES
(34).
The molten globule state during folding presumably adopts a pro-
gressively more compact packing of its secondary structure elements,
resulting in the formation of ordered tertiary structure (102). We propose
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314 HARTL, MARTIN &NEUPERT
that this reaction occurs by a mechanism of partial release while the protein
remains in close association with GroEL. Unproductive interactions could
be reversed, utilizing the energy of rebinding to GroEL, since these inter-
actions would not allow the successful internalization of structural
elements recognized by GroEL. Eventually, the protein would be set free
in a conformation still before or already past the transition state of the
folding pathway. In the case of oligomeric proteins such as Rubisco (71,
72), the monomers associated with GroEL are likely to assume the con-
formation of a folding intermediate able to associate with other subunits.
Stabilization by GroEL would increase the concentration of this type of
rate-limiting intermediate for the assembly reaction. It seems reasonable
to assume that oligomerization takes place upon ATP-dependent release
of the GroEL-bound monomers. Molecules that were unsuccessful in
finding the proper partner to associate with could rebind to GroEL, there-
by avoiding unwanted interactions.
Although how the chaperonins could increase the rate of an assembly
reaction is evident, whether they actually catalyze the folding ofmonomeric
polypeptide chains is unclear. Do the chaperonins mediate folding by
lowering the activation energy of the productive folding pathway, or do
they do so exclusively by raising energy barriers blocking pathways that
lead to misfolding and aggregation?
ATP REQUmEMENT OF FOLDING Research has not formally shown that
GroES may not interact directly with the polypeptide substrate folding at
GroEL. According to the present view, however, the key to the function
of GroES lies in its regulatory influence on the ATP-hydrolytic activity of
GroEL (18, 123, 192). The GroEL 14-met probably has 14 ATP binding
sites. In the absence of substrate, the GroEL complex exhibits a low but
significant ATPase activity with a Km for ATP of 7 #M (192). This activity
is almost completely suppressed by interaction with GroES at a l: 1 molar
ratio of GroES 7-met to GroEL 14-mer (123, 192). GroES and GroEL
form an isolatable complex in the presence of Mg-ATP or ADP (18, 192;
A. Girshovich, unpublished data; J. Martin, unpublished data). Under
the influence of GroES, the GroEL ATPase becomes strictly substrate
dependent 023). In the case of rhodanese, approximately 100 molecules
of ATP were hydrolyzed per protein molecule folded, suggesting that the
GroEL 14-mer went through several cycles of ATP hydrolysis (123). The
amount of ATP required for folding in vivo is unknown; one should keep
in mind that the synthesis of a single molecule of rhodanese (293 residues)
consumes roughly 1200 molecules of ATP, i.e. the ATP requirement for
chaperonin-mediated folding will probably be a comparatively minor
expense.
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A HYPOTHESIS FOR THE FOLDING OF NEWLY
SYNTHESIZED POLYPEPTIDES
Recent findings for protein folding in mitochondria may suggest a principle
mechanism for the acquisition of tertiary structure in vivo. Division of
labor between molecular chaperones of the HspT0 and Hsp60 families
appears to be an integral element (76, 141). Although members of both
groups of stress proteins interact with unfolded or incompletely folded
polypeptides and utilize the energy of ATP hydrolysis for releasing the
bound substrates, important functional differences are becoming apparent.
Physiological folding of a newly synthesized polypeptide may occur by the
following three-step reaction consisting of (a) protection and maintenance
of folding competence by Hsp70, (b) ATP-dependent transfer from Hsp70
to Hsp60, and (c) ATP-dependent folding at Hsp60 (Figure 
Maintenance of Folding Competence by Hsp 70
Components of the Hsp70 family can associate with the folding poly-
peptide before those of the Hsp60 family, suggesting a hierarchy of inter-
action with molecular chaperones. For example, the mitochondrial Hsp70
binds to the extended protein sequences reaching into the matrix while
¯ they are still in the process of membrane translocation (94, 145, 170).
Similarly, cytosolic Hsp70 is thought to interact with nascent polypeptides
emerging from the ribosome (5). Hsp70 binds unfolded peptide sequences
(60, 61) and exhibits the highest binding affinities with mutant polypeptides
that have little stable secondary structure (147; J. M. Flanagan, G. C.
Flynn, J. Walter, J. E. Rothman & D. M. Engelman, submitted).
The main purpose of the interaction of a nascent polypeptide chain with
Hsp70 would be to prevent premature (mis)folding and aggregation 
proteins (or their independently folding domains) during synthesis. It 
unknown how many Hsp70 molecules could bind to a sequence of, say, 100
amino acids emerging from a ribosome (statistically containing perhaps up
to 5 binding sites) (61). Binding of Hsp70 could prevent or retard 
hydrophobic collapse of the molecule, and the emerging chain would
transiently be held in a relatively extended conformation with little stable
secondary structure. The initial binding may require the cooperation
between Hsp70 and a DnaJ-homologous component. Because of its slow,
ATP-dependent release activity, bound Hsp70 would fall off the substrate
perhaps with kinetics adjusted to the speed of protein synthesis (60).
This would allow the internalization of hydrophobic regions to a molten
globule-like state now stabilized by fewer Hsp70 molecules.
The interaction with Hsp70 alone appears not to be sufficient to promote
the formation of ordered tertiary structure, at least in the case of proteins
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316 HARTL, MARTIN & NEUPERT
imported into the mitochondrial matrix (94). The role of Hsp70 in protein
folding could mainly consist of stabilizing the newly synthesized chains in
loose conformations competent for the folding process mediated by a
further component(s) or for membrane translocation (so-called "folding-
competent" and "translocation-competent" states). Alternatively, the sta-
bilization of nascent chains followed by cycles of ATP-dependent release
and rebinding of Hsp70 may be sufficient for the folding of a subset of
total soluble proteins that might contain sequence elements supporting
the productive interaction with HspT0. In fact, the existence of sequence
information that ensures that a newly synthesized protein forms the correct
intermediate conformations on the folding pathway was demonstrated by
the mutational analysis of the in vivo folding of P22 tailspike polypeptide
(69, 70, 129). This information is not required to stabilize the native state
of the protein. Because of coevolution with molecular chaperones, proteins
may contain structural elements directing the programmed interaction
with these components.
Transfer from HspTO to Hsp60
Folding in mitochondria appears to depend on the newly imported proteins
being transferred from Hsp70 to Hsp60 (94, 144). Very little is known
about this transfer reaction. In light of the finding that binding of Hsp70
is necessary for membrane translocation, while Hsp60 function appears to
be of little importance at this stage (94, 144), transfer to Hsp60 should
occur when import of the protein (or its domains in case of larger poly-
peptides) is complete. Other mitochondrial components, perhaps similar
to the NEM-sensitive factor contained in reticulocyte lysates (136), may
have to cooperate with Hsp70 to ultimately allow its complete release
from the imported protein. Natural candidates could be mitochondrial
homologues of E. coli DnaJ and GrpE that are known to physically
interact with the Hsp70 DnaK (66). Homologues of DnaJ have been
reported for mitochondria (7), for the yeast nucleus (17), and for 
cytosol (17, 119). In addition to their roles in DNA replication (43, 
202), DnaJ, DnaK, and GrpE have as yet undefined functions of general
importance for normal growth of E. coli (13, 14, 66, 174) that may include
protein folding (65). DnaK is dispensable at intermediate growth tem-
peratures around 30°C (although the cells grow very poorly) and becomes
essential for growth at tempcraturcs below and above 30°C (13, 14). 
present, all results would be compatible with DnaK having a critical buffer
function in protein folding, holding and protecting nascent chains until
they can be taken over by GroEL. Under non-heat-shock conditions, cells
would contain fewer GroEL molecules than nascent chains; the basal level
of the GroEL 14-met is about 15 ~tM, while the concentration of nascent
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chains is 30-50 #M and that of DnaK is 100 :tM (calculated according to
refs. 35, 73, 139). Furthermore, GroEL may bind nascent chains only at
a later stage of synthesis than DnaK and would therefore be unable to
efficiently prevent their aggregation. This lack of protection would become
more critical at higher growth temperatures. We propose that DnaK,
DnaJ, and GrpE cooperate with GroE/GroES in the de novo folding of
proteins.
Hsp60-Mediated Folding
Evidently, Hsp70 cannot assume some specific functions of Hsp60 in
protein folding. The chaperonins appear to mediate folding by a process
of step-wise release while the folding polypeptide remains sequestered at
their surface (123, 144). Surface-mediated folding may critically depend
on an oligomeric machinery in which the individual Hsp60 monomers
contribute binding sites for polypeptide segments whose action would be
coordinated in the oligomeric chaperonin complex.
Although both mitochondrial Hsp60 and E. coli GroEL/GroES fulfill
essential functions under all growth conditions (51), it is unclear what
percentage of total proteins depend on chaperonins for folding. Given the
importance for protein folding we assign to Hsp60, one would expect that
chaperonin-like components were present in every cellular compartment
capable of de novo folding. A functional equivalent of Hsp60 in the
eukaryotic cytosol has not been found so far, but a remote structural
homology to GroEL and mitochondrial Hsp60 has been reported for the
TCP-1 protein complex (1), which led to the proposal of a molecular
chaperone function for TCP- 1 (49), a high-molecular-weight complex simi-
lar in size to that of the chaperonins (V. Lewis & K. Willison, personal
communication). TCP-1 was originally described as involved in the
phenomenon of male-specific transmission ratio distortion in mice (120,
176). The protein is abundantly expressed in developing sperm, but a more
general function is suggested by the detection of TCP-1 in the cytosol of
all other cell types analyzed to date (186, 205). A cold-sensitive mutation
in yeast affecting TCP-1 impairs mitotic spindle formation (187). The
recent discovery of the thermoprotection factor TF55 of the thcrmophilic
archaebacterium Sul_/blobus shibatae makes TCP-1 a very attractive can-
didate for an Hsp60-1ike function in the cytosol (185). TF55, the major
heat-shock protein of S. shibatae, appears to be an 18-met complex of 55-
kDa subunits with ~ 40% sequence identity to TCP-1 of mouse and yeast
(185). These findings may support speculations on the existence of two
evolutionary lines of chaperonins, one leading from eubacteria to mito-
chondria and chloroplasts and the other leading from archaebacteria to
the eukaryotic cytosol.
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FUTURE ASPECTS
It is now generally accepted that protein folding in the cell needs mediation
by molecular chaperone components. Despite considerable advances
towards understanding the function of Hsp70 and Hsp60, many aspects
of their molecular mechanisms of action are still unclear. We are just
beginning to understand how unfolded proteins are recognized and how
their folding is prevented or promoted. In no case is the structural basis
for binding fully established. While at least a partial crystal structure of
Hsp70 is available, such information is completely lacking for the Hsp60
components. Remaining questions include: How is ATP hydrolysis trans-
formed into conformational changes of the chaperone, ultimately resulting
in folding of the protein substrate? Or, from a more cell-biological point
of view, what is the exact sequence of interactions with chaperones during
and following synthesis of a polypeptide chain? Can these processes, for
example the functional cooperation between Hsp70 and Hsp60, faithfully
be reproduced in vitro? Given the significance and the current interest in
aspects of protein folding in vivo, we will probably not have to wait long
for the answers to many of these questions.
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